Laquinimod treatment in the R6/2 mouse model

The transgenic mouse model R6/2 exhibits Huntington’s disease (HD)-like deficits and basic pathophysiological similarities. We also used the pheochromocytoma-12 (PC12)-cell-line-model to investigate the effect of laquinimod on metabolic activity. Laquinimod is an orally administered immunomodulatory...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Sci Rep
Egile Nagusiak: Ellrichmann, Gisa, Blusch, Alina, Fatoba, Oluwaseun, Brunner, Janine, Reick, Christiane, Hayardeny, Liat, Hayden, Michael, Sehr, Dominik, Winklhofer, Konstanze F., Saft, Carsten, Gold, Ralf
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Nature Publishing Group UK 2017
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5504033/
https://ncbi.nlm.nih.gov/pubmed/28694434
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-017-04990-1
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak